Saxatilin, a snake venom disintegrin, regulates platelet activation associated with human vascular endothelial cell migration and invasion

Journal of Vascular Research

Volumn 44, Issue 2, 2007, Pages 129-137

  Jang, Yoon Jung ^a   Jeon, Ok Hee ^a   Kim, Doo Sik ^a  

^a Yonsei University   (South Korea)

Author keywords

Angiogenesis; Chemotaxis; Endothelial cell; Platelet; Saxatilin

Indexed keywords

COLLAGEN; INTEGRIN; INTEGRIN ALPHA2B BETA3; PLATELET DERIVED GROWTH FACTOR B; PROTEIN KINASE SYK; SAXATILIN; SNAKE VENOM; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM;

BLOOD PLATELETS; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; DISINTEGRINS; ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHAVBETA3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE KINASES; UMBILICAL VEINS; UP-REGULATION;

EID: 33847020705     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098519     Document Type: Article

References (50)

1. Andrews RK, Berndt MC: Platelet physiology and thrombosis. Thromb Res 2004;114:447-453.
2. Gibbins JM: Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci 2004;117:3415-3425.
3. Weyrich AS, Lindemann S, Zimmerman GA: The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.
4. Wagner DD, Burger PC: Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003;23:2131-2137.
5. Weber C: Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005;96:612-616.
6. Barry OP, FitzGerald GA: Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999;82:794-800.
7. Pinedo HM, Verheul HM, D'Amato RJ, Folkman J: Involvement of platelet in tumour angiogenesis? Lancet 1998;352:1775-1777.
8. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ: Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005;113:752-760.
9. Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ: Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002;30:450-459.
10. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, Watzek G: Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 2004;1:29-35.
11. Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, Preissner KT: The functional role of blood platelet components in angiogenesis. Thromb Haemost 2004;92:394-402.
12. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005;67:30-38.
13. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934.
14. Ferrara N: Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999;237:1-30.
15. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C: Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999;126:3047-3055.
16. Hirschi KK, Rohovsky SA, D'Amore PA: PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998;14:805-814.
17. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
18. Eliceiri BP, Cheresh DA: Role of αv integrins during angiogenesis. Cancer J 2000;6:S245-S249.
19. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA: Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998;140:1255-1263.
20. Hood JD, Frausto R, Kiosses WB, Schwartz MA, Cheresh DA: Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol 2003;162:933-943.
21. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin αv β3 for angiogenesis. Science 1994;264:569-571.
22. Kang IC, Chung KH, Lee SJ, Yun Y, Moon HM, Kim DS: Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom. Thromb Res 1998;91:65-73.
23. Kang IC, Lee YD, Kim DS: A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res 1999;59:3754-3760.
24. Kim SI, Kim KS, Kim HS, Kim DS, Jang Y, Chung KH, Park YS: Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors. Cancer Res 2003;63:6458-6462.
25. Hong SY, Koh YS, Chung KH, Kim DS: Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Thromb Res 2002;105:79-86.
26. Hong SY, Sohn YD, Chung KH, Kim DS: Structural and functional significance of disulfide bonds in saxatilin, a 7.7 kDa disintegrin. Biochem Biophys Res Commun 2002;293:530-536.
27. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C: A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994;216:444-450.
28. Castellon R, Hamdi HK, Sacerio I, Aoki AM, Kenney MC, Ljubimov AV: Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 2002;74:523-535.
29. Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W: Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 2000;79:850-857.
30. Tan KT, Lip GY: The potential role of platelet microparticles in atherosclerosis. Thromb Haemost 2005;94:488-492.
31. Rendu F, Brohard-Bohn B: The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001;12:261-273.
32. Claesson-Welsh L: Mechanism of action of platelet-derived growth factor. Int J Biochem Cell Biol 1996;28:373-385.
33. Woodard AS, Garcia-Cardena G, Leong M, Madri JA, Sessa WC, Languino LR: The synergistic activity of αvβ3 integrin and PDGF receptor increases cell migration. J Cell Sci 1998;111:469-478.
34. Schneller M, Vuori K, Ruoslahti E: αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J 1997;16:5600-5607.
35. You WK, Jang YJ, Chung KH, Kim DS: A novel disintegrin-like domain of a high molecular weight metalloprotease inhibits platelet aggregation. Biochem Biophys Res Commun 2003;309:637-642.
36. Shattil SJ, Gao J, Kashiwagi H: Not just another pretty face: regulation of platelet function at the cytoplasmic face of integrin alpha IIb beta 3. Thromb Haemost 1997;78:220-225.
37. Judge HM, Buckland RJ, Holgate CE, Storey RF: Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses. Platelets 2005;16:398-407.
38. Ogawa T, Sugidachi A, Otsuguro K, Isobe T, Asai F: Platelet α-granule secretion and its modification by SC-57101A, a GPIIb/IIIa antagonist. Biochem Pharmacol 2002;63:1911-1918.
39. Ilveskero S, Lassila R: Abciximab inhibits procoagulant activity but not the release reaction upon collagen- or clot-adherent platelets. J Thromb Haemost 2003;1:805-813.
40. Massberg S, Mueller I, Besta F, Thomas P, Gawaz M: Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting. Am Heart J 2003;146:E19.
41. Klinkhardt U, Kirchmaier CM, Westrup D, Breddin HK, Mahnel R, Graff J, Hild M, Harder S: Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters. Thromb Res 2000;97:201-207.
42. Canobbio I, Balduini C, Torti M: Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004;16:1329-1344.
43. Andrews RK, Lopez JA, Berndt MC: Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997;29:91-105.
44. Chen H, Kahn ML: Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Bio 2003;23:4764-4777.
45. 3 during outside-in integrin platelet signaling. J Biol Chem 2000;275:36423-36429.
46. 1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCγ2. J Cell Biol 2003;160:769-780.
47. Falati S, Edmead CE, Poole AW: Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor γ-chain, Fyn, and Lyn to activate human platelets. Blood 1999;94:1648-1656.
48. Poole AW, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JG, Saito T, Tybulewicz VL, Watson SP: The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997;16:2333-2341.
49. 3 . Thromb Haemost 2005;93:932-939.
50. Watson SP: Collagen receptor signaling in platelets and megakaryocytes. Thromb Haemost 1999;82:365-376.